We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
Cap. Flow
+$3.24B
Cap. Flow %
0.88%
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.69B
2
NOW icon
ServiceNow
NOW
+$651M
3
AMAT icon
Applied Materials
AMAT
+$563M
4
V icon
Visa
V
+$536M
5
CCL icon
Carnival Corporation Ltd
CCL
+$523M

Sector Composition

Rank Sector Weight
1 Technology 30.9%
2 Financials 11.41%
3 Consumer Discretionary 10.18%
4 Industrials 9.65%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMNB icon
2201
Farmers National Banc Corp
FMNB
$899M
$2.28M ﹤0.01%
172,902
+113,181
+190% +$1.49M
USPH icon
2202
US Physical Therapy
USPH
$1.14B
$2.27M ﹤0.01%
30,267
+176
+0.6% +$14.4K
HRMY icon
2203
Harmony Biosciences
HRMY
$2.04B
$2.27M ﹤0.01%
80,975
-2,129
-3% -$69.8K
CNXN icon
2204
PC Connection
CNXN
$2.05B
$2.26M ﹤0.01%
38,651
+4,595
+13% +$275K
TIC
2205
TIC Solutions Inc
TIC
$1.58B
$2.25M ﹤0.01%
342,617
+1,370
+0.4% +$12.9K
RR icon
2206
Richtech Robotics
RR
$347M
$2.25M ﹤0.01%
1,075,947
+818,105
+317% +$2.52M
INGN icon
2207
Inogen
INGN
$167M
$2.25M ﹤0.01%
363,682
-49,777
-12% -$307K
TRVI icon
2208
Trevi Therapeutics
TRVI
$2.49B
$2.25M ﹤0.01%
188,182
+4,853
+3% +$54.3K
PINE
2209
Alpine Income Property Trust
PINE
$339M
$2.24M ﹤0.01%
124,659
+85,391
+217% +$1.59M
RAPP
2210
Rapport Therapeutics
RAPP
$1.95B
$2.24M ﹤0.01%
71,508
+562
+0.8% +$15.8K
ALKT icon
2211
Alkami Technology
ALKT
$1.8B
$2.22M ﹤0.01%
141,977
-4,567
-3% -$84.1K
TRDA icon
2212
Entrada Therapeutics
TRDA
$227M
$2.22M ﹤0.01%
175,648
+119,232
+211% +$1.37M
NUVB icon
2213
Nuvation Bio
NUVB
$2.24B
$2.21M ﹤0.01%
514,117
-2,337,884
-82% -$13M
PRAA icon
2214
PRA Group
PRAA
$648M
$2.19M ﹤0.01%
125,051
-14,477
-10% -$220K
PSNL icon
2215
Personalis
PSNL
$1.26B
$2.19M ﹤0.01%
343,520
+34,840
+11% +$294K
RPAY icon
2216
Repay Holdings
RPAY
$315M
$2.19M ﹤0.01%
840,952
-343,715
-29% -$1.1M
CRVS icon
2217
Corvus Pharmaceuticals
CRVS
$1.1B
$2.18M ﹤0.01%
149,126
+81,062
+119% +$1.29M
TK icon
2218
Teekay
TK
$975M
$2.18M ﹤0.01%
178,257
+1,900
+1% +$21K
GIII icon
2219
G-III Apparel Group
GIII
$1.47B
$2.17M ﹤0.01%
78,309
-3,488
-4% -$102K
LMB icon
2220
Limbach Holdings
LMB
$867M
$2.16M ﹤0.01%
27,687
+226
+0.8% +$19K
NSP icon
2221
Insperity
NSP
$1.85B
$2.16M ﹤0.01%
79,791
-197,110
-71% -$6.34M
KALV
2222
DELISTED
KalVista Pharmaceuticals
KALV
$2.15M ﹤0.01%
106,864
-265
-0.2% -$4.27K
HTBK
2223
DELISTED
Heritage Commerce
HTBK
$2.14M ﹤0.01%
171,719
-494,680
-74% -$6.28M
NBN icon
2224
Northeast Bank
NBN
$1.11B
$2.14M ﹤0.01%
19,054
-747
-4% -$84.4K
LEG icon
2225
Leggett & Platt
LEG
$1.52B
$2.14M ﹤0.01%
216,465
-6,637
-3% -$75.8K

Similar funds

Nuveen's Q1 2026 Portfolio in Review

As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
  • Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
  • Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
  • Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
  • Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
  • Nuveen opened 48 new positions and closed 76 in Q1 2026.
  • Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.